# Ultromics

> Ultromics is a UK-based clinical AI company (GV-backed, Oxford spin-out) whose EchoGo platform applies FDA 510(k)-cleared AI to routine echocardiograms to detect heart failure with preserved ejection fraction (HFpEF) and cardiac amyloidosis. EchoGo integrates with existing hospital echo workflows and PACS environments; Ultromics publishes no public developer API.

## Products

- [EchoGo Platform](https://www.ultromics.com/about-ultromics-the-platform): Cloud AI analysis of echocardiograms, delivered through clinical systems and PACS
- [Clinical Evidence](https://www.ultromics.com/clinical-evidence): Published studies backing EchoGo Heart Failure and EchoGo Amyloidosis

## Company

- [Website](https://www.ultromics.com/)
- [About](https://www.ultromics.com/about-ultromics)
- [News](https://www.ultromics.com/press-releases)
- [Contact](https://www.ultromics.com/contact-us)

## Trust & Legal

- [Trust Centre](https://trust.ultromics.com/): ISO/IEC 27001:2022, ISO 13485:2016, HIPAA, GDPR, NHS DSPT
- [Privacy Notice](https://www.ultromics.com/privacy-notice)

## API Evangelist profile

- [APIs.json](https://raw.githubusercontent.com/api-evangelist/ultromics/refs/heads/main/apis.yml): Machine-readable profile of Ultromics in the API Evangelist network